Clinical Trial Update: Safety, PK and PD of FLQ-101 in Premature Neonates [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update discusses safety, pharmacokinetics and pharmacodynamics of FLQ-101 in premature neonates with Retinopathy of Prematurity and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• FLQ-101

Snippet

Sponsor: FELIQS INC. | Conditions: Retinopathy of Prematurity (ROP) | Phase 1 | Status: RECRUITING